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Abstract 
Background: ApaH like phosphatases (ALPHs) originate from the bacterial ApaH protein and have been identified 
in all eukaryotic super-groups. Only two of these proteins have been functionally characterised. We have shown that 
the ApaH like phosphatase ALPH1 from the Kinetoplastid Trypanosoma brucei is the mRNA decapping enzyme of 
the parasite. In eukaryotes, Dcp2 is the major mRNA decapping enzyme and mRNA decapping by ALPHs is unprec-
edented, but the bacterial ApaH protein was recently found decapping non-conventional caps of bacterial mRNAs. 
These findings prompted us to explore whether mRNA decapping by ALPHs is restricted to Kinetoplastida or could be 
more widespread among eukaryotes.
Results: We screened 827 eukaryotic proteomes with a newly developed Python-based algorithm for the presence 
of ALPHs and used the data to characterize the phylogenetic distribution, conserved features, additional domains 
and predicted intracellular localisation of this protein family. For most organisms, we found ALPH proteins to be 
either absent (495/827 organisms) or to have non-cytoplasmic localisation predictions (73% of all ALPHs), excluding a 
function in mRNA decapping. Although, non-cytoplasmic ALPH proteins had in vitro mRNA decapping activity. Only 
71 non-Kinetoplastida have ALPH proteins with predicted cytoplasmic localisations. However, in contrast to Kineto-
plastida, these organisms also possess a homologue of Dcp2 and in contrast to ALPH1 of Kinetoplastida, these ALPH 
proteins are very short and consist of the catalytic domain only.
Conclusions: ALPH was present in the last common ancestor of eukaryotes, but most eukaryotes have either lost 
the enzyme, or use it exclusively outside the cytoplasm. The acceptance of mRNA as a substrate indicates that ALPHs, 
like bacterial ApaH, have a wide substrate range: the need to protect mRNAs from unregulated degradation is one 
possible explanation for the selection against the presence of cytoplasmic ALPH proteins in most eukaryotes. Kineto-
plastida succeeded to exploit ALPH as their only or major mRNA decapping enzyme. 71 eukaryotic organisms outside 
the Kinetoplastid lineage have short ALPH proteins with cytoplasmic localisation predictions: whether these pro-
teins are used as decapping enzymes in addition to Dcp2 or else have adapted to not accept mRNAs as a substrate, 
remains to be explored.
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Background
Eukaryotic phosphatases play essential roles in regulating 
many cellular processes and can be classified in several 
ways, based on catalytic mechanism, substrate speci-
ficity, ion requirements and structure. One four-group 
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classification distinguishes phosphoprotein phosphatases 
(PPPs), metal-dependent protein phosphatases (PPM, 
sometimes classified as a subgroup of PPP), protein 
tyrosine phosphatases and aspartic acid-based phos-
phatases [1]. The eukaryotic PPP group includes the Ser/
Thr phosphatases PP1, PP2A, PP2B, PP4, PP5, PP6 and 
PP7 [1, 2] but has been extended to include three families 
of bacterial origin: Shewanella-like SLP phosphatases, 
Rhizobiales-like (RLPH) phosphatases and ApaH-like 
(ALPH) phosphatases [3–6].
ApaH like phosphatases (ALPHs) evolved from the 
bacterial ApaH protein and were present in the last com-
mon ancestor of eukaryotes [3, 5]. They are widespread 
throughout the entire eukaryotic domain, although 
they have been lost in certain sub-branches such as 
land plants and chordates [6]. To the best of our knowl-
edge, only two ALPHs have been functionally charac-
terised to date. One is the S. cerevisiae ALPH protein 
(YNL217W), a  Zn2+ dependent endopolyphosphatase 
of the vacuolar lumen [7] that is also active with  Co2+ 
and possibly  Mg2+ [8]. The enzyme’s main function is 
the cleavage of vacuolar poly(P). A function of Ppn2 in 
stress response is suggested by the fact that the increase 
in short polyphosphate upon Ppn2 overexpression corre-
lates with an increased resistance to peroxide and alkali 
[9]. The second characterised ALPH protein is ALPH1 
of the Kinetoplastida Trypanosoma brucei: we recently 
found that ALPH1 is the only or major trypanosome 
mRNA decapping enzyme [10], the enzyme that removes 
the  m7 methylguanosine  (m7G) cap present at the 5´end 
of most eukaryotic mRNAs. This finding was surprising, 
as all other known eukaryotic mRNA decapping enzymes 
belong to a different enzyme family, the nudix hydro-
lases (the prototype is Dcp2). Trypanosomes lack ortho-
logues to Dcp2 and all decapping enhancers associated 
with Dcp2, but use the ApaH like phosphatase ALPH1 
instead. T. brucei ALPH1 consists of the catalytic domain 
with N- and C- terminal extensions of about equal sizes, 
that appear unique to Kinetoplastida and bear no simi-
larities to any known domains.
Interestingly, recent data indicate, that the bacterial 
precursor protein of ALPH, ApaH, may have an analo-
gous function to Trypanosome ALPH1 in decapping of 
bacterial mRNAs. In  vitro, ApaH cleaves diadenosine 
tetraphosphate (Ap4A) into two molecules of ADP [11, 
12], but is also active towards other NpnN nucleotides 
(with n ≥ 3) [13–15]. Deletion of the ApaH gene causes a 
marked increase in Np4A levels and a wide range of phe-
notypes [16–23]. Np4A was therefore suggested to act 
as an alarmone (a signalling molecule involved in stress 
response), but no Np4A receptor has yet been identified. 
Instead, recent data show that stress induced increase in 
Np4A levels cause massive nucleoside-tetraphosphate 
capping of bacterial mRNAs [24] mostly or entirely 
caused by usage of Np4A as non-canonical transcrip-
tion initiation nucleotide [25]. Many other dinucleoside 
polyphosphates can be used for co-transcriptional cap-
ping even in the absence of stress, including methylated 
versions [26]. ApaH is the major decapping enzyme for 
all dinucleoside polyphosphate caps [24, 26], suggesting 
that its main function is to regulate gene expression by 
modulating the mRNA decapping process. Intriguingly, 
the enzyme can both enhance decapping (by decapping 
nucleoside-tetraphosphate capped RNA) and inhibit 
decapping (by cleaving Np4A and preventing its incorpo-
ration to the mRNA).
Puzzled by these novel functions of bacterial ApaH and 
trypanosome ALPH1 in mRNA decapping, we here set 
out to investigate whether mRNA decapping is a major 
function of eukaryotic ALPHs, or whether this function 
is restricted to trypanosomes. We developed a Python 
algorithm for the identification of ALPHs in all avail-
able eukaryotic reference proteomes and identified 441 
ALPHs in 332/827 proteomes. We show that most ALPH 
proteins consist exclusively of the catalytic domain and 
many have predicted transmembrane regions or signal 
peptides and predicted non-cytoplasmic localisation, 
indicating functions distinct from mRNA decapping. 
We show in vitro mRNA decapping activity for three of 
these non-cytoplasmic ALPH proteins, indicating that, 
similar to bacterial ApaH, eukaryotic ALPHs accept 
non-physiological substrates and thus are likely to have 
a rather wide substrate range. The data indicate that 
there may be selection against the presence of cytoplas-
mic ALPH proteins in eukaryotes, possibly to protect 
mRNAs from unregulated degradation. Apart from the 
kinetoplastids, only 71 organisms possess ALPH proteins 
with cytoplasmic localisation predictions. In contrast to 
the Kinetoplastida, these ALPH proteins consisted (with 
2 exceptions) of the catalytic domain only and all organ-
isms have an orthologue to Dcp2 (with 3 exceptions likely 
caused by genome incompleteness).
Results
Identification of ApaH like phosphatases in available 
eukaryotic proteomes
ALPHs belong to the PPP family of phosphatases and 
possess the four conserved signature motifs (motif 1–4) 
of this family, GDxHG, GDxxDRG, GNHE, and HGG, 
sometimes with conservative substitutions [2]. One 
distinctive feature of ALPHs are two changes in the 
GDxxDRG motif: The second Asp is replaced by a neu-
tral amino acid and the Arg residue is replaced by Lys. In 
addition, ALPHs have two C-terminal motifs [3, 6] that 
we here call motif 5 and 6. We screened 827 complete 
ukaryotic proteomes (Additional file 3: Table S1a) for the 
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presence of ApaH like phosphatases with a home-made 
Python algorithm; these included all reference proteomes 
available on UniProt [27] and all available Kinetoplastida 
proteomes available on TriTrypDB [28, 29]. The algo-
rithm is based on recognising the six sequence-motifs 
that are characteristic for ALPHs. The matrices used to 
define these motifs were optimised stepwise using yeast 
and Kinetoplastida proteomes to not miss any ALPH 
(controlled by BLAST) while on the other hand not to 
recognise PPPs, and in particular not the closely related 
phosphatases SLP, RLPH and ApaH (sequences taken 
from [6]). The final algorithm also included restrictions 
on distances between the motifs 1 to 2, 2 to 3 and 5 to 6 
that we found highly conserved. More details are in mate-
rial and methods. BLAST screens on selected proteomes 
without ALPH proteins revealed that ALPHs were either 
fully absent or, in rare cases, present in a truncated ver-
sion and missing at least one of the motifs, mostly the 
N- or C-terminal one. ALPH proteins with missing N- 
or C-terminal motifs may have arisen from sequencing 
or annotation errors and were not included in the final 
list (Additional file 4: Table S2c) (11 proteins in total, all 
belong to phylogenetic groups with ALPH proteins pre-
sent). Only for the Kinetoplastida, ALPHs with wrongly 
annotated start codons were manually included (based 
on comparison with related Kinetoplastida and available 
genome information).
Figure 1 summarises all organisms of this study in phy-
logenetic groups based on the latest eukaryotic classifi-
cation suggested by [30]. For each group, the fraction of 
organisms with and without ALPH is indicated in orange 
and blue, respectively. 332 of all 827 organisms included 
in this study have at least one ALPH, and these organ-
isms are distributed in a patchy way throughout all 
eukaryotes. Most Euglenozoa have ALPHs (32 of 33), 
many Stramenopiles (25 of 28) and Fungi (238 of 298), 
but also Rhodophyceae (3 of 4), Chlorophyta (11 of 18), 
Haptista (2 of 2) and some Metazoa (17 of 296). ALPHs 
are absent from land plants (100 proteomes tested), Api-
complexa (20 proteomes tested), Ciliata (3 proteomes 
tested) and Dinoflagellates (1 proteome tested). They are 
largely absent from Chordata (134 proteomes tested, only 
Branchiostoma floridae has ALPH) and from Ecdysozoa 
(144 proteomes tested, only 4 Arachnida have ALPH) 
and fully absent from the few available proteomes of 
Amoebozoa (9 proteomes tested) and Metamonada (3 
proteomes tested). A phylogenetic tree built from the 
catalytic domains of ALPHs mostly reflects the eukary-
otic tree (Additional file 1: Figure S1). Taken together, the 
data indicate that ALPH was present in the last common 
ancestor of all eukaryotes and was then selectively lost 
in certain sub-branches. Our data fully agree with the 
data of [6], regarding absences and presences of ALPH 
proteins in eukaryotic subgroups. We extend the availa-
ble dataset from 52 ALPHs (38 organisms) to 441 ALPHs 
(332 organisms), this way providing a better resolution of 
ALPH distribution across eukaryotes.
The aim of this work was not to analyse horizontal 
gene-transfer between eukaryotes, bacteria and archaea; 
however, we could confirm the presence of ALPHs 
in a subgroup (11/25) of Myxococcales, as described 
in [6] (Additional file  5: Table  S3A). We detected 
ALPH in 1 of 285 archaean proteomes (OX = 1906665 
GN = EON65_52185, UniProt: UP000292173) (Addi-
tional file 5: Table S3B); it is possible that this protein is a 
contamination. All prokaryotic ALPHs consisted mostly 
of the catalytic domain with almost no N- or C terminal 
extensions.
General features of ApaH‑like phosphatases
The dataset was used to refine the characteristics of 
ALPH proteins (Fig.  2). 40% of all analysed organisms 
have at least one ALPH isoform. The highest percent-
age is found in Discoba with 94%, the lowest in Diapho-
retickes with 24% (Fig.  2A). Of the 332 APLH-positive 
organisms, 25% have more than one ALPH isoform: most 
(81%) have two and with one exception no organism 
has more than four (Fig.  2B). Organisms with multiple 
ALPHs were mostly enriched among the Discoba (94% 
of organisms with ALPH had at least 2 ALPHs) (Fig. 2B). 
The vast majority of all ALPH proteins are very short and 
consist mainly of the catalytic domain with short N- and 
C-terminal extensions (Fig.  2C). The median size of the 
C-terminal extensions is 26 amino acids: only 52 of all 
441 ALPH proteins have C-termini extending 100 amino 
acids and most of these (31) are ALPHs of Discoba. The 
size of the N-terminus is slightly more variable and has 
a median of 87 amino acids. Only 61 of all 441 ALPH 
proteins have N-termini extending 200 amino acids and 
many of these (28) belong to ALPHs of Discoba. The 
largest variance in the size of ALPH N- and C-termini is 
found in Discoba, reflecting the presence of two different 
ALPH variants in the Kinetoplastida (discussed below).
The amino acid distances between some of the ALPH 
motifs are highly conserved (Fig. 2D): 93.7% of all ALPHs 
have between 28 and 30 amino acids between motif 1 and 
2 (72% have exactly 29). The distance between motif 2 
and 3 is exactly 26 amino acids for 83.0% of ALPHs and 
between 25 and 33 for 98.0% of ALPHs. The distance 
between the two C-terminal motifs 5 and 6 is exactly 19 
amino acids for 92.5% of ALPHs. The distances between 
motif 3 and 4 are well conserved in ALPHs of Diapho-
retickes and Discoba (94% are between 55 and 64 amino 
acids) but less well within Amorphea. The distances 
between motif 4 and 5 are poorly conserved. Sequence 
motifs were created for all six motifs (Fig.  2E) [31]. 
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Mostly, these are conserved with some group-specific 
preferences at certain positions indicated with orange 
bars (Fig.  2E). The ALPH sequence of S. cerevisiae is 
shown as an example, to illustrate the definitions of all 
features discussed above (Fig. 2F).
Fig. 1 Presence and absence of ALPH in the different eukaryotic subgroups. 827 eukaryotic proteomes were screened for the presence of ALPH. 
Absence or presence of ALPH is shown in pie diagrams in blue and orange, respectively, for each phylogenetic group. The diameter of a circle 
roughly reflects the number of available proteomes. The phylogenetic tree was taken from [30]. All organisms are listed in Additional file 3: Table S1
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Fig. 2 General Features of ALPHs. A Proteomes with (orange) and without (blue) ALPHs. B Number of ALPH proteins per organism. C Sizes of the 
different ALPH ‘domains’ (N-terminus, catalytic domain, C-terminus) are presented as box plot (waist is median; box is IQR; whiskers are ± 1.5 IQR) 
and in addition as individual data points (transparent blue circles). The catalytic domain is defined as the range between the first and last motif, with 
an additional six N-terminal amino acids and an additional eight C-terminal amino acids (compare F). D Distances between the six different motifs 
(in amino acids) are presented as box plot (waist is median; box is IQR; whiskers are ± 1.5 IQR) and in addition as individual data points (transparent 
blue circles). E Sequence motifs were created with WebLogo [31]. The most obvious differences between the three groups are marked with orange 
bars. F The sequence of ALPH from S. cerevisiae is shown as a typical example, to illustrate the position of the catalytic domain (blue), the N- and 
C-termini (grey) as well as all six motifs (red) and the distances between the motifs that we found most conserved (green). Details on all data 
presented in Fig. 2 can be found in Additional file 3: Table S1
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ALPHs of Opisthokonts (fungi and holozoa)
The majority of available ALPH sequences (292) are from 
Fungi, because the number of available proteomes is high 
(298) and 80% of these proteomes contain at least one 
ALPH. We investigated these ALPH sequences further 
by looking for predicted domains (Interpro [32]), signal 
peptides and trans-membrane helices (Phobius [33] and 
Target P [34]) and predicted localisation (DeepLoc [35] 
and WoLF PSORT [36]) (Fig.  3A and Additional file  3: 
Table  S1b). ALPHs of Fungi have very short C-termini 
(median = 26 amino acids) and only slightly larger N-ter-
mini (median = 97 amino acids). Most fungal ALPHs 
(95.2%) do not contain any predictable domain in addi-
tion to the catalytic ALPH domain. Of the 14 ALPHs that 
have a further domain, three have domains with func-
tions in cytochrome c complex assembly (IPR021150, 
IPR018793) indicating mitochondrial functions and five 
ALPHs have a THIF-type NAD/FAD binding fold, usu-
ally found in the ubiquitin activating E1 family, indicat-
ing a possible function in protein degradation. The ALPH 
of Lentinula edodes has a Peroxin-3 domain, indicating a 
peroxisomal function. Two ALPHs of Rachicladosporium 
have Pectate lyase domains, indicating a possible function 
in degradation of cell wall material. ALPH of Phycomyces 
blakesleeanus has a spore coat protein CotH (IPR014867) 
domain, a domain of bacterial origin with unknown func-
tion in eukaryotes. The ALPH of Rhizopogon vesiculosus 
has a second ALPH domain.
The most interesting finding was the presence of pre-
dicted trans-membrane regions and/or signal pep-
tides within the C-terminal region in 78.1% of all fungal 
ALPH proteins: 184 ALPH proteins have predicted 
membrane helices (mostly one), a further 41 ALPH 
proteins have predicted signal peptides, 3 ALPH pro-
teins have both predicted and only 64 ALPH proteins 
have neither predicted (Fig. 3A and B, Additional file 3: 
Table S1b). In agreement with these data, only 49 ALPH 
proteins (16.8%) have predicted cytoplasmic localisa-
tion (mostly the ones without predicted membrane heli-
ces and signal peptides) (Fig. 3A and B, Additional file 3: 
Table  S1b). The remaining proteins are predicted to be 
in the golgi (52.1%), endoplasmatic reticulum (19.5%), 
mitochondrion (6.5%), lysosome/vacuole (3.8%), nucleus 
(2 proteins, 0.7%), peroxisome (1 protein, 0.3%) and 
extracellular (1 protein, 0.3%). Prediction data need to 
be considered with care in the absence of experimen-
tal evidence, but taken together, the data provide strong 
evidence for the majority of fungal APLH proteins being 
non-cytoplasmic. Experimental data confirm non-cyto-
plasmic localisation for the ALPH protein of S. cerevisiae 
(YNL217w, Ppn2): two high-throughput studies indicate 
vacuolar localisation [37, 38] and recent data show that 
Ppn2 is delivered to the vacuolar lumen via the multive-
sicular body pathway, where it functions as an endopoly-
phosphatase [7].
ALPHs are underrepresented in Holozoans (Fig. 1). In 
particular, all 130 vertebrate proteomes lack ALPHs and 
of the three available non-vertebrate proteomes of Chor-
data, only the Lancelet Branchiostoma floridae is ALPH-
positive. Out of the 140 available Ecdysozoan proteomes, 
only four organisms (Arachnida species) contain ALPH. 
ALPHs are present in subgroups of Cnidarians (2/3), 
Echinodermatans (1/2), Lophotrochozoens (8/11), Pla-
cozoans (1/2) and Ichthyosporeans (1/2). 7 of these 18 
Holozoan ALPH proteins have a predicted signal pep-
tide or transmembrane helix at their C-termini and with 
the exception of ALPH from Lottia gigantea, all proteins 
have non-cytoplasmic localisation predictions, mostly 
to the mitochondria (13/18) (Fig.  3C, Additional file  3: 
Table  S1c). Two proteins have an additional domain: 
ALPH of Pomacea canaliculata has a domain of the 
FAD/NAD(P)-binding superfamily N- terminal of the 
catalytic domain and ALPH of Leptotrombidium deliense 
may be interacting with actin, as it has a Kaptin domain 
C-terminal of its ALPH domain.
All the 42 organisms containing an ALPH protein with 
a cytoplasmic localisation prediction also have a Dcp2 
homologue (Blast, Additional file  3: Table  S1b and c), 
indicating that a function of the ALPH protein in mRNA 
decapping, if present, is not exclusive.
ALPHs of diaphoretickes
We found no ALPHs in land plants (100 proteomes), 
Apicomplexa (20 proteomes), Ciliata (3 proteomes) or 
Dinoflagellata (1 proteome). ALPH is present in 3 of 4 
species of red algae, 11 of 18 species of green algae (Chlo-
rophyta), in the filamentous green algae Klebsormidium 
nitens, in the photosynthetic Alveolate Vitrella brassica-
formis, in the cryptophyte algae Guillardia theta and in 
the two available Haptista proteomes. 25 of 28 Strameno-
piles have ALPHs: These are mostly (non-photosyn-
thetic) Oomycetes, including for example Phytophthora 
Fig. 3 ALPHs of Opisthokonts. A ALPH proteins of Fungi are presented as schematics with their catalytic domain and additional predicted features 
(further domains, transmembrane helices, signal peptides) (right). Localisation predictions (Target P, DeepLoc) are shown on the left. The organism 
names and more details can be found in Additional file 3: Table S1b. B Pie charts summarizing localisation predictions (DeepLoc) (left) and predicted 
transmembrane helix or signal peptides (right) for ALPH proteins from all Fungi. C ALPH proteins from Holozoa are presented as in (A). More details 
are listed in Additional file 3: Table S1c
 
(see figure on next page.)
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parasitica: all the strains of this plant pathogen have 
three ALPH isoforms. Predicted signal peptides or trans-
membrane helices are present at the C-termini of many 
Chloroplastida ALPHs (11/19), as well as in ALPH pro-
teins of the Alveolata Vitrella brassicaformis, the diatom 
Phaeodactylum tricornutum and the Haptista Emiliania 
huxleyi; in all cases the presence of transmembrane 
helices or signal peptides correlates with a predicted 
non-cytoplasmic localisation (Fig.  4). With two excep-
tions, all 19 ALPH proteins from Chloroplastida have non-cytoplasmic localisation predictions (11 mito-
chondrion, 4 chloroplast, 2 endoplasmic reticulum). 
In contrast, the remaining 74 ALPH proteins from 
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Fig. 3 continued
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non-Chloroplastida have mostly cytoplasmic localisation 
predictions, with only 7 exceptions (6 mitochondrion, 1 
chloroplast).
The majority of ALPH proteins from Diaphoretickes 
is very short and, in particular ALPHs of Oomycetes, 
consist almost exclusively of the catalytic domain with 
very short N- and C-terminal extensions. Of all 63 Dia-
phoretickes ALPH proteins, only five have additional 
domains: the ALPH of Chlamydomonas reinhardtii has 
a predicted Transposase IS605 domain (a transposon 
of bacterial origin), the ALPH of Helicosporidium has a 
coatomer delta subunit domain and the three large and 
almost identical ALPH proteins of Chlorella sorokini-
ana have a PsbQ-like domain (IPR023222), an Arm-like 
repeat and a second ALPH domain. A PsbQ-like domain 
is typical for proteins of the photosystem II, consistent 
with localisation predictions of the three Chlorella soro-
kiniana ALPH proteins to the chloroplast.
Of the 29 Diaphoretickes that have ALPH proteins 
with predicted cytoplasmic localisation, 26 have a readily 
identifiable homologue to Dcp2 of Arabidopsis thaliana 
(in some cases only as a fragment as proteomes were 
not complete) (Additional file  3: Table  S1d). The three 
remaining organisms with no identifiable Dcp2 homo-
logue are Chrysochromulina tobinii, Hyaloperonospora 
arabidopsidis and Pythium insidiosum. However, closely 
related species to all three organisms have Dcp2 and it 
is likely that the absence of a Dcp2 is caused by genome 
incompleteness: the proteome of C. tobinii is 37% incom-
plete and the proteomes of H. arabidopsidis and P. insid-
iosum are 7% and 1% incomplete, respectively. Thus, any 
function of an ALPH protein in mRNA decapping is 
likely not exclusive but occurs in addition to Dcp2.
ALPHs of Euglenozoa
ALPHs are present in all Kinetoplastida and in their close 
relative Euglena gracilis (Additional file  3: Table  S1e). 
The only exception is the free-living, non-parasitic Bodo 
saltans.
Fig. 4 ALPHs of Diaphoretickes. ALPHs of Diaphoretickes are presented as schematics with their catalytic domain (dark blue) and additional 
predicted features (further domains, transmembrane helices and signal peptides) (right) and localisation predictions (Target P and DeepLoc) (left). 
More details are listed in Additional file 3: Table S1d
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ALPHs of Kinetoplastida fall into two groups (Fig. 5A): 
each organism has exactly one ALPH that is homologous 
to T. brucei ALPH1, the mRNA decapping enzyme [10]. 
These ALPHs all have a C-terminal extension of between 
220 and 278 amino acids and, with two exceptions (Lep-
tomonas pyrrhocoris and T. grayi), they all have N-ter-
minal extensions of a similar size. The in  vitro mRNA 
decapping activity of T. brucei ALPH1 does not require 
the N-terminus [10], and the two ALPHs that lack the 
N-terminus are therefore also likely active in mRNA 
decapping. The fact that no Kinetoplastida strain has lost 
its ALPH1 homologue, and the absence of homologues 
to the canonical mRNA decapping enzymes (DCP1/
DCP2), indicates that all Kinetoplastida rely on ALPH1 
for mRNA decapping.
In addition to the ALPH1 homologue, all but one 
Kinetoplastid have between one and three additional 
ALPH proteins that consist exclusively of the catalytic 
domain (Fig.  5A). These ALPH proteins of Leishmania, 
Leptomonas, Crithidia and Endotrypanum have exten-
sions within the catalytic domain that are mainly caused 
by enlarged distances between motif 1 and 2 (up to 115 
nucleotides in Leptomonas and Crithidia, more than 
in any other ALPH) and between motif 4 and 5 (up to 
156 nucleotides). The only Kinetoplastida that has no 
ALPH apart from ALPH1 is Leishmania tarentolae; blast 
searches identified a protein at the expected position in 
the genome which lacked both motif 5 and motif 6, indi-
cating a recent loss of the protein.
Differences between the two different groups of Kineto-
plastida ALPH proteins are also obvious within the phos-
phatase and ALPH motifs: several positions show major 
differences; most pronounced is the difference in motif 1 
(GDVHG/GDIHG for ALPH1/non-ALPH1) and in motif 
6 (IDTG/LDSG for ALPH1/non-ALPH1) (Fig. 5B). When 
a phylogenetic tree is constructed from the sequences of 
the catalytic domains, the Kinetoplastida ALPH1 homo-
logues form a separate group, distant to the group of the 
non-ALPH1 homologues, indicating that the ALPH1 
decapping enzyme has evolved only once in the last com-
mon ancestor of the Kinetoplastida (Fig. 5A).
Protein localisation predictions are difficult in Eugleno-
zoa as these organisms have diverse and poorly defined 
targeting signals: localisation predictions from Phobius, 
DeepLoc and Target P are listed in Additional file  3: 
Table S1e but do not correlate well with each other, and, 
in particular not with our experimental data. The decap-
ping enzyme T. brucei ALPH1, fused to eYFP either C- or 
N- terminally, localises to the cytoplasm, P-bodies and to 
the posterior pole of the cell and this cytoplasmic locali-
sation is consistent with the essential function of ALPH1 
in mRNA decapping ([10] Fig. 5A). It is likely that ALPH1 
orthologues of all other Kinetoplastida have predominant 
cytoplasmic localisations too. To investigate the locali-
sation of an non-ALPH1 homologue, T. brucei ALPH2 
was expressed as C-terminal eYFP fusion in procyclic 
trypanosomes using an inducible expression system [39]. 
ALPH2 showed a localisation pattern characteristic of 
mitochondrial proteins and co-localised with a mito-
chondrial stain (MitoTracker™ Orange) (Fig. 5A).
Euglena is too distantly related to the Kinetoplastida 
to unequivocally assign its ALPH to the ALPH1 or 
non ALPH1 group, but its sequence motifs (GDIHG, 
GDLVGKG, GNHD, HAG, VFFGH, LDTG) are more 
similar to the non-ALPH1 group and this is also sug-
gested by the absence of N- and C-terminal extensions 
(Fig. 5A). Interestingly, Euglena ALPH is the only Kine-
toplastida ALPH with a predicted trans-membrane 
domain. Euglena ALPH was not enriched within purified 
mitochondria fractions [40] and also not within chlo-
roplasts (Martin Zoltner, Charles University in Prague, 
personal communication). Like Kinetoplastida, Euglena 
has no recognisable homologue to the canonical mRNA 
decapping enzyme DCP1/DCP2 in its genome and the 
absence of an ALPH1 homologue raises the question of 
how mRNA decapping is achieved in this organism.
As previously reported, Blast searches cannot iden-
tify a Dcp2 homologue in Kinetoplastida, with the one 
exception of Perkinsela (not examined in this study) [10]. 
Perkinsela is an obligate intracellular component of the 
Amoebozoa Neoparamoeba. Its Dcp2 has closest simi-
larity to Dcp2 of flowering plants and the gene may have 
been taken up by lateral gene transfer.
ALPHs have in vitro mRNAs decapping activity
The phylogenetic data from us and others [6] show that 
ApaH like phosphatases were present in the last common 
ancestor of eukaryotes. Since then, 60% of eukaryotes 
have lost the enzyme and of those ALPH proteins that 
are still present, 73% have predicted non-cytoplasmic 
localisations. ALPH proteins are pyrophosphatases and 
at least the related bacterial ApaH protein has a rather 
Fig. 5 ALPHs of Euglenozoa. A ALPH proteins of Euglenozoa are presented schematically along a maximum likelihood phylogenetic tree based on 
an alignment of the catalytic domains. All details on Euglenozoa ALPHs are listed in Table S1e. The localisation of T. brucei ALPH1 and ALPH2 was 
determined by expressing eYFP fusion proteins. One representative fluorescent image is shown for each protein. At least three different clonal cell 
lines showed identical localisation. B Sequence motifs of the ALPH1 orthologues and the non-ALPH1 orthologues. Major differences are marked by 
asterisks
(See figure on next page.)
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broad substrate specificity and cleaves for example both 
NpnN nucleotides [13–15] as well as mRNA capped with 
NpnN [24, 26]. The need to protect capped mRNAs from 
uncontrolled degradation may create selection for the 
loss or non-cytoplasmic localisation of eukaryotic ALPH 
proteins. To test this hypothesis, we tested ALPH pro-
teins with non-cytoplasmic localisation prediction for 
mRNA decapping activity in vitro.
We produced recombinant ALPH proteins from 
randomly selected organisms of the three eukaryotic 
kingdoms that have ALPHs: we used ALPH of the Ich-
thyosporea Sphaeroforma arctica, ALPH of the green 
algae Auxenochlorella protothecoides (A0A087SQ73) and 
ALPH2 from Trypanosoma brucei (ALPH2 has mito-
chondrial localisation and is not the mRNA decapping 
enzyme). As a control, ALPH of Sphaeroforma arctica 
was also produced as an inactive mutant by mutating a 
conserved amino acid in the metal ion binding motif 
(GDVIG:GNVIG [41]). All four proteins were purified 
from Arctic express cells (Fig.  6A) and subsequently 
tested in in vitro decapping assays using a 39 nucleotide 
long RNA oligo with a  m7G cap structure as a substrate. 
Capped and uncapped oligos can be distinguished by 
differences in gel mobility on urea acrylamide gels com-
plemented with acryloylaminophenyl boronic acid [42, 
43]. The decapping activity of the three active enzymes 
was tested in the presence of different bivalent ions 
 (Mg2+,  Mn2+,  Co2+ and  Zn2+) (Fig. 6B). All the enzymes 
had mRNA decapping activity, but the ion requirements 
for optimal activity differed: the ALPH of Sphaeroforma 
arctica showed the highest decapping activity with  Mn2+ 
and some activity with  Co2+, but none with  Mg2+ or 
 Zn2+. T. brucei ALPH2 had the best decapping activity 
with  Co2+ and some with  Mg2+ and possibly  Mn2+, but 
none with  Zn2+. Auxenochlorella protothecoides ALPH 
had the best activity with  Mg2+ and some with  Co2+, 
but none with  Zn2+ and  Mn2+. These differences in ion 
requirements indicate that the enzyme activities are 
likely specific and not caused by contaminating bacterial 
enzymes, which would be expected to require identical 
ions in all samples. Moreover, the catalytically inactive 
mutant ALPH of Sphaeroforma arctica had no decapping 
activity, when tested with its supportive ion  (Mn2+), fur-
ther strong evidence for the specificity of the decapping 
activity.
The data show that all ALPH enzymes tested accept 
capped mRNA as a substrate in  vitro. Importantly, the 
tested ALPH proteins have non-cytoplasmic localisation 
Fig. 6 ALPH proteins have mRNA decapping activity. A Recombinant ALPH proteins were produced in Arctic Express DE cells and purified via 
Nickel affinity chromatography. A Coomassie stained gel loaded with the purified proteins (red asterisk) is shown. Note that the Arctic Express DE 
cells contain chaperons (yellow asterisk). Chaperonin Cpn60 is often co-purified, in the case of TbALPH2 to a large extent. B The enzymes were 
tested for in vitro decapping activity in the presence of 1 mM of divalent ions, as indicated. A reaction without enzyme served as negative control. 
For each enzyme, an asterisk marks the conditions for best decapping activity. The gels are representative gels out of at least three replicates. An 
inactive mutant of Sphaeroforma arctica has no activity (last lane)
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predictions, indicating that mRNA cannot be their physi-
ological substrate. Instead, the findings suggest that 
ALPH proteins may have a similar broad substrate speci-
ficity as previously shown for bacterial ApaH. The data 
support the hypothesis that the preference for none or 
non-cytoplasmic ALPHs in many eukaryotes could serve 
to prevent uncontrolled mRNA degradation.
Discussion
mRNAs are essential molecules in both eukaryotes and 
prokaryotes and need to be protected from unregu-
lated exonucleolytic degradation. 5´-3´exoribonucleases 
require monophosphorylated RNA 5´ends and the major 
protection strategy is therefore to avoid such monophos-
phates. Most eukaryotic mRNAs are modified at their 
5´end by an  m7 methylguanosine  (m7G) cap, linked via 
an inverted 5´-5´bridge [44]. A small fraction of eukary-
otic RNAs carries non-canonical nucleotide metabolite 
caps, for example an NAD + cap [45, 46]. Bacteria were 
long believed to simply keep the triphosphate that is 
naturally present at their 5´end after transcription, but 
more recently were found to have diphosphate 5´ends 
[47], and also non-canonical metabolite caps, such as 
the NAD + cap [48], the 3-dephospho-coenzyme A cap 
(dpCoA) [49] or dinucleoside polyphosphate caps [24–
26]. Archaea mRNAs are not well studied but do carry 
triphosphates caps [50].
In common to the increasing number of different 
mRNA caps and mRNA 5´ end modifications discov-
ered throughout all kingdoms of life is the pyrophosphate 
bond, and therefore the requirement of a pyrophos-
phatase to remove the cap or the polyphosphate. 
Enzymes of four different families can cleave pyrophos-
phate bonds at the 5´end of mRNAs [51]. DXO and his-
tidine triad (HIT) proteins, act mainly on faulty RNAs or 
on cap remnants or remove non-canonical NAD + caps 
without cleaving the pyrophosphate bond [51]. This 
leaves two pyrophosphatase families that act on intact 
mRNAs. Nudix domain proteins include the prototypic 
eukaryotic mRNA decapping enzyme Dcp2 [52] and sev-
eral further eukaryotic nudix hydrolases with activity to 
the  m7G cap and non-canonical metabolite caps [53–55] 
as well as the bacterial RppH [56] and NudC proteins 
[57] that act on di- or triphosphorylated mRNAs and on 
NAD + caps [51]. Enzymes of the fourth group, the ApaH 
family only entered the field of mRNA decapping most 
recently. The ApaH like phosphatase ALPH1 from Trypa-
nosoma brucei was shown to be the only or major mRNA 
decapping enzyme in these parasites [10]. Bacterial ApaH 
cleaves of non-canonical nucleoside-tetraphosphate 
caps [24–26] and likely regulates gene expression during 
stress.
The major aim of this work was to find out how wide-
spread mRNA decapping by ApaH like phosphatases 
is. To identify ALPH proteins in all available eukaryotic 
proteomes, we have developed a Python based algorithm 
based on recognising the six conserved motifs of ALPH. 
We detected 441 ALPH proteins in 332 of 827 organisms. 
The full details of these 441 ALPH proteins are summa-
rized in Additional file  3: Table  S1 and contribute to a 
more comprehensive knowledge of this enzyme family.
What is the likelihood for these 441 ALPH proteins 
to function in mRNA decapping? The most stringent 
criterion is intracellular localisation: mRNA decapping 
enzymes must be cytoplasmic to access their substrates. 
321/441 ALPH proteins have non-cytoplasmic localisa-
tion prediction and these predictions correlate in many 
cases with predicted transmembrane helices and signal 
peptides (Fig. 7). For two ALPH proteins, yeast Ppn2 and 
T. brucei ALPH2, non-cytoplasmic predictions were con-
firmed experimentally [7, 37, 38], this work). This leaves 
120 ALPH proteins with predicted cytoplasmic localisa-
tion. A second essential feature of an mRNA decapping 
enzyme is the need to regulate its activity: For the nudix 
domain protein Dcp2, this regulation is done by the 
N-terminal domain, which mediates interactions with 
decapping enhancers [58]. The T. brucei mRNA decap-
ping enzyme ALPH1 has unique N- and C-terminal 
extensions and the C-terminal extensions are conserved 
across all Kinetoplastida ALPH1 homologues and it is 
therefore tempting to speculate that they contribute to 
enzyme regulation. 87 of the 120 ALPH proteins with 
cytoplasmic predictions consist of the catalytic domain 
only (Fig.  7). The absence of additional sequences does 
not preclude the protein from being an mRNA decap-
ping enzyme, but any interaction with putative decapping 
regulators must occur directly via the catalytic domain. 
The remaining 33 proteins that have sequences in addi-
tion to the catalytic domain include the 31 Kinetoplastida 
homologues to the T. brucei mRNA decapping enzyme 
ALPH1, the ALPH protein of the fungi Moniliophthora 
roreri (Gamma-glutamyl cyclotransferase-like domain) 
and the ALPH protein of Ectocarpus siliculosus (disor-
dered regions) (Fig.  7). A third criteria to evaluate the 
likelihood of an ALPH enzyme to act in decapping is to 
look for the presence of an alternative mRNA decapping 
enzyme. Orthologues to the mRNA decapping enzyme 
Dcp2 were readily detectable by Blast in all organisms 
with cytoplasmic ALPH proteins, with the marked excep-
tion of the Kinetoplastida. To summarize, if any ALPH 
proteins from non-Kinetoplastida function in mRNA 
decapping, they are unlikely the exclusive mRNA decap-
ping enzyme and their regulation will, with two possible 
exceptions, entirely depend on the catalytic domain.
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All three ALPH proteins that we tested had mRNA 
decapping activity in  vitro, even though none of these 
enzymes is likely to use mRNA as their physiological 
substrate as all three have (predicted or proven) mito-
chondrial localisation. This broad substrate range of 
ALPHs is not unexpected: the related bacterial ApaH 
protein cleaves NpnN nucleotides [13–15] as well was 
mRNA capped with NpnN [24, 26] and even has phos-
phatase and ATPase activity in addition to its pyrophos-
phatase activity [59]. The only other characterised ALPH 
protein, the S. cerevisiae ALPH protein Ppn2 has, to our 
knowledge, not been tested for mRNA decapping activ-
ity. Substrate unspecificity is not restricted to ApaH and 
ApaH like phosphatases, but also found in (decapping) 
enzymes of the nudix domain family [60]: the major bac-
teria decapping enzyme RppH was initially identified as 
diadenosine polyphosphate hydrolase [61] and can also 
cleave  NAD+ caps [55]. Recent in vitro studies of mam-
malian nudix proteins shows that many have mRNA 
decapping activity towards a range of caps and some also 
towards free metabolites [53, 55, 62, 63]; how many of 
these nudix proteins have mRNAs as their natural sub-
strates is still debated.
The broad substrate range of ALPHs that includes 
mRNA caps provides an explanation for its loss or non-
cytoplasmic localisation in most eukaryotes. The last 
Fig. 7 Summary of the major findings of this work. For the ALPH proteins of Kinetolastida, non-cytoplasmic localisation was assumed for the 
non-ALPH1 orthologues and cytoplasmic localisation for ALPH1 orthologues, based on localisation studies in Trypanosoma brucei (Fig. 5)
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common ancestor of all eukaryotes had ALPH. This 
assumption is supported by the presence of ALPH pro-
teins in all eukaryotic kingdoms found in this and earlier 
[6] studies. With the evolution of the eukaryotic mRNA 
cap, eukaryotes faced two problems: first, the cap needed 
to be protected from unregulated degradation by pyroph-
osphatases and second, an mRNA decapping enzyme 
was needed for regulated degradation. The first chal-
lenge was likely addressed in multiple ways, including 
for example protection by cap binding proteins like the 
eIF4F complex. One important evolutionary strategy may 
have been to inactivate the bacterial-inherited ALPH 
proteins. Many eukaryotes fully lost these bacterial-
derived enzymes or at least did not tolerate cytoplasmic 
localisation. Evolution has solved the second challenge by 
evolving pyrophosphatases as regulatable mRNA decap-
ping enzymes. Usually, nudix hydrolases were exploited 
for this task, but Kinetoplastida uniquely use one of their 
ALPH proteins. Some non-Kinetoplastida have ALPH 
proteins with predicted cytoplasmic localisation: if these 
ALPH proteins are indeed cytoplasmic, they could act 
in mRNA decapping in addition to Dcp2 or else, they 
may have been evolved to not accept capped mRNA as a 
substrate.
One open question is whether all organisms outside 
the Kinetoplastida use DCP2 orthologues as their major 
mRNA decapping enzyme. While DCP2 has been func-
tionally characterised in yeast [52], human [64] and 
plants [65], there are no experimental data on Meta-
monada and Discoba. Metamonada species possibly have 
a DCP2 homologue: in Trichomonas this can be identi-
fied by Blast and in Giardia by more sophisticated in 
silico methods [66, 67]. Whether Discoba have DCP2 is 
unclear. A possible DCP2 homologue is identifiable by 
blast in the Discoba Naegleria, but not in Euglena. The 
question whether DCP2 was present in the last com-
mon ancestor and selectively lost in Kinetoplastida, or 
whether it evolved subsequently to the separation of the 
Discoba cannot be answered without experimental data.
In the last few years, more and more mRNA cap vari-
ants have been discovered in both prokaryotes and 
eukaryotes, and more and more enzymes that act in 
mRNA decapping, including ApaH like phosphatases 
and bacterial ApaH. Our analysis of eukaryotic ApaH 
like phosphatases is an important contribution towards a 
more comprehensive picture of mRNA decapping.
Conclusions
Despite being present in all eukaryotic kingdoms, ApaH 
like phosphatases are poorly understood with only a few 
studies available. Here, we present a new algorithm for 
the identification of ALPH proteins and we provide a 
comprehensive dataset of ApaH like phosphatases of all 
available reference proteomes. Trypanosomes and possi-
bly a few other organisms use ALPH proteins for mRNA 
decapping; however, the physiological functions of the 
vast majority of eukaryotic ALPH proteins remain to be 
discovered. In vivo experiments are essential, as the wide 




A novel algorithm was developed using Python 3 to iden-
tify ALPHs in a set of proteome fasta files. The algorithm 
initially used narrow matrices to identify the 6 conserved 
motifs (4 common to all PPP and 5–6 unique to ALPHs) 
based on the data of [3, 6], these matrices were succes-
sively extended manually using a set of yeast proteomes 
and euglenozoan proteomes as training sets, controlled 
by BLAST. These initial screens gave information about 
conserved and non-conserved distances between the 6 
motifs. Proteins that had only one motif missing were 
manually inspected further. If they possessed the miss-
ing motif in an only slightly different version (e.g. only 
one amino acid altered in a conservative way) and, at 
the same time, had the correct distances between the 
motifs (where these distances are conserved), the motif 
matrix was extended to include this motif. One excep-
tion was made for R at position 6 in motif 2: this is not 
tolerated, as it prevented the clear distinction of ALPHs 
from the related ApaH and RLPH enzymes [6]. Several 
rounds of manual iterations and matrix improvements 
resulted in an algorithm that uses one narrow matrix for 
the initial screen and, if not all motifs were found, the 
algorithm tolerates up to two motifs from an extended 
matrix. Furthermore, we included restrictions to three 
of the distances between the motifs. This algorithm was 
run with all 827 proteomes and identified 430 ALPH pro-
teins. Thereafter, we screened all 827 proteomes for ‘one 
motif missing’, successively at each position (data shown 
in Additional file 4: Table S2a). Manual analysis of these 
data resulted in three further changes to the matrix and 
identification of 11 additional ALPH proteins (details in 
Additional file 4: Table S2a). The final software was run 
again on all 827 proteomes but did not identify any addi-
tional ALPH proteins. In the final version of the software, 
the narrow matrices are defined as [G, D, VILT, HQ, G], 
[G, DN, LMIFVT, EIVTLAC, NSATFGVQIDHM, KQN, 
GASHT], [G, N, HNWQ, ED], [H, AG, G], [VIT, IVY-
FLAMT, FY, G, H], [LVIMT, DE, STG, GASRN] for motif 
1, 2, 3, 4, 5 and 6, respectively. The extended matrices 
are defined as [GxX, DxX, VILTxX, HQxX, GxX], [GxX, 
DNxX, TIFLYVMxX, ETIALCVMxX, EQTIASDFGH-
CVNMxX, KQNxX, GASHTxX], [GxX, NxX, HNWQxX, 
EDxX], [HxX, AGLVxX, GxX], [AVILCMTxX, 
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IVYFLAMTxX, FYxX, GxX, HxX], [LVIMTxX, DExX, 
LATGSVxX, LMGRASNExX] for motif 1, 2, 3, 4, 5 and 
6, respectively. Furthermore, the algorithm restricts the 
distances between the motifs to 14–150 (motif 1 to 2), 
25–80 (motif 2 and 3) and 17–40 (motif 5 to 6). As one 
further control to ensure that all ALPH proteins were 
identified, we screened all 827 proteomes again with 
matrices tolerating more amino acids at positions in the 
motifs that appeared less conserved (matrices shown in 
Additional file 4: Table S2b): again, no further ALPH pro-
teins were identified.
ALPHs with missing motifs due to wrongly annotated 
start codons or sequencing errors will not be detected, 
with the exception of an unidentified amino acid 
included in the extended matrix (x, X). For the Kine-
toplastida, such ALPHs were manually included based 
on the available genome information from TriTrypDB 
[28, 29]; for all other organisms, such truncated ALPH 
proteins (11 in total) are listed in Additional file  4: 
Table S2c.
Finally, all proteins were manually inspected: even 
though the extended sequence matrix would allow the 
presence of motifs with little homology to the consensus 
motif, we found that the extended matrix was used rather 
rarely (1.9% of all motifs, affecting 11.3% of all ALPH pro-
tein; no ALPH protein had 2 motifs form the extended 
matrix) and if so, the extended motifs had still most 
amino acids from the narrow matrix. The Python pro-
gramme is available in Additional file 2: Python Software.
Cloning and expression of recombinant proteins
All ALPH proteins were expressed either full length (T. 
brucei ALPH2 = Tb927.4.4330) or with minor N-termi-
nal truncations to exclude the transmembrane regions 
(Sphaeroforma arctica: amino acids 21–316; Auxeno-
chlorella protothecoides: amino acids 21–327) in Arctic 
Express DE competent cells (Agilent). At the N-terminus, 
the proteins were fused to a tag consisting of a 6xHis-
Tag, a Thrombin cleavage site, a SUMO tag and a TEV 




RL ME AFAK RQ GK E MDSLRFLYD GIRIQAD QT-
PEDLDMEDNDIIEAHREQIGGHMENLYFQGEASAT. 
For cloning reasons, all proteins had the extension 
GSGSGC at the C-terminus. For the inactive mutant of 
the Sphaeroforma arctica ALPH, the highly conserved 
GDVIG motif involved in metal ion binding was mutated 
to GNVIG [41]. The purification of the recombinant 
proteins was done via Nickel-agarose beads using stand-
ard procedures as previously described [10], except that 
expression in Arctic Express DE cells was done at 10 °C, 
following the instructions of the company. The con-
centration of all purified proteins was estimated from 
Coomassie gels using a titration of a protein with known 
concentration for calibration.
Phylogeny
The tree of the Euglenozoa ALPHs (Fig.  5) was done 
with all ALPH catalytic domains (defined as starting 
6 amino acids upstream of motif 1 and ending 8 amino 
acids downstream of motif 6) using MEGA X [68, 69]. 
All the sequences were aligned using Muscle (gap open 
−2.90; gap extend: 0.00; Hydrophobicity Multiplier: 
1.20; Max Iterations: 16; Cluster Method: UPGMA; Min 
Diag Length (Lambda): 24) [70] and gaps were manually 
removed. The best protein substitution model was calcu-
lated: JTT + G + I (BIC = 23908). The tree was built using 
the Maximum Likelihood method (500 bootstrap cycles) 
and the JTT matrix-based model [71]. The tree with the 
highest log likelihood (−11295.89) is shown. The per-
centage of trees in which the associated taxa clustered 
together is shown next to the branches. Initial tree(s) 
for the heuristic search were obtained automatically by 
applying Neighbor-Join and BioNJ algorithms to a matrix 
of pairwise distances estimated using the JTT model, and 
then selecting the topology with superior log likelihood 
value. A discrete Gamma distribution was used to model 
evolutionary rate differences among sites (5 categories 
(+ G, parameter = 1.0217). The rate variation model 
allowed for some sites to be evolutionary invariable (+ I, 
6.38% of sites).
Different methods (minimal evolution, neighbour join-
ing) gave slightly different trees, but, importantly, with 
all methods, the ALPH1 isoforms group together in one 
clade that never contains non-ALPH1 isoforms.
Proteomes
Proteomes were downloaded from Uniprot, using 
all available reference proteomes of UniProt_release 
2019_02 (For Archaea: 2019_11). [27]. Additional file  3: 
Table S1a lists all proteomes used in this work. For Kine-
toplastida, we downloaded all available proteomes from 
TriTrypDB (February 2019) [28, 29]. During the revision 
process, we screened UniProt_release 2021_01 selec-
tively for all phylogenetic groups (Fig. 1) that had no ref-
erence proteomes available in UniProt_release 2019_02: 
this search identified proteomes of two Haptista and one 
Dinoflagellate.
Work with trypanosomes
Trypanosoma brucei Lister 427 procyclic cells expressing 
a TET repressor (pSPR2.1) were used for all experiments 
[39]. Cells were cultured in SDM-79 [72] at 27 ℃ and 5% 
 CO2. Transgenic trypanosomes were generated using 
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standard procedures [73]. All experiments used logarith-
mically growing trypanosomes. The mitochondria were 
stained by adding 1  µM MitoTracker™ Orange CMTM-
Ros (Invitrogen) to living cells; imaging was done within 
30 min.
Microscopy
Z-stack images (100 stacks at 100  nm distance) were 
taken with a custom build TILL Photonics iMic micro-
scope equipped with a sensicam camera (PCO), decon-
volved using Huygens Essential software (Scientific 
Volume Imaging B. V., Hilversum, The Netherlands). 
All images are presented as Z-projections (method sum 
sliced) produced by ImageJ software.
In vitro decapping assays
Each decapping reaction was done in 10 µl volume (with 
RNAse-free water) containing 50  mM Tris–HCl (pH 
7.9), 100 mM NaCl, 1 mM metal ions (variable), 40 units 
Ribolock RNAse inhibitor (ThermoFisher Scientific), 
0.25  µM recombinantly-produced ALPH enzyme and 
0.39  µM capped RNA oligo  m7G-AAC UAA CGC UAU 
UAU UAG AAC AGU UUC UGU ACU AUA UUG (Bio-Syn-
thesis, Texas, USA). The sample was incubated for 1  h 
at 37 °C. Control reactions were done without enzymes. 
The reaction was stopped by ethanol precipitation: 1  µl 
3 M RNAse-free sodium acetate (pH 5.5) (Ambion), 1 µl 
RNAse-free glycogen (ThermoFisher Scientific) and 30 µl 
cold 100% ethanol was added, the sample incubated at 
−20  °C for 30  min, followed by centrifugation (15  min, 
20,000  g). The pellet (containing the RNA oligo) was 
washed once in 80% ethanol, air-dried, resolved in 5  µl 
RNAse-free water (ThermoFisher Scientific) and either 
stored at −80  °C or directly prepared for loading to the 
gel.
RNA Samples were separated on urea acrylamide 
gels that contained acryloylaminophenyl boronic acid 
[42, 43]: boronyl groups form stable complexes with the 
 m7G cap structure, this way increasing the difference in 
gel mobility between capped and uncapped oligos [42, 
43]. For 12% gels, a 10  ml gel solution was freshly pre-
pared with distilled water, containing 12% acrylamide/
bis-acrylamide (19:1) (Sigma-Aldrich), 7 M urea (Sigma-
Aldrich), 0.1% ammonium persulfate, 4  µl TEMED, 
0.25% acryloylaminophenyl boronic acid (Sigma-Aldrich) 
and 100  mM Tris–acetate (pH 9.0). Gels were run in 
0.5 × TBE buffer (45 mM Tris–HCl pH 8.3, 45 mM boric 
acid, 1 mM EDTA) using the Mini-PROTEAN Tetra Ver-
tical Electrophoresis cell (gel size 10 × 8  cm, BioRad). 
Each run was preceded by a 30 min pre-run at 300 V to 
warm the gel. The purified RNA samples were prepared 
for gel electrophoresis by adding 1  µl loading dye (gel 
loading buffer II, Invitrogen) followed by incubation at 
95 °C for 5 min. Samples were loaded immediately to the 
pre-rinsed wells of the pre-run gel and the gel was run 
at 200  V (after a 10  min run at 170  V) for 30–40  min, 
stained for 20  min in SYBR™ Green II RNA Gel Stain 
(1:10,000 in 0.5 × TBE, ThermoFisher Scientific) and 
imaged on the iBright™ (Invitrogen) with nucleic acid 
settings.
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